Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2017 ∙ Adamo, G. Sturabotti, G. D'Andrea, E. Baccolini, V. Romano, F. Iannazzo, S. Marzuillo, C. Villari, P.

The end of measles and congenital rubella: an achievable dream?

  • Europe
  • Italy
  • All age groups
  • Measles
  • Rubella
  • Efficacy/effectiveness
  • Safety
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2017 ∙ Cafiero-Fonseca, E. T. Stawasz, A. Johnson, S. T. Sato, R. Bloom, D. E.

The full benefits of adult pneumococcal vaccination: a systematic review

  • Adults
  • Older adults
  • Pneumococcal disease
  • Economic aspects
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Not applicable
2017 ∙ Forshaw, J. Gerver, S. M. Gill, M. Cooper, E. Manikam, L. Ward, H.

The global effect of maternal education on complete childhood vaccination: a systematic review and meta-analysis

  • Newborn
  • Children
  • Parents/caregivers
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2017 ∙ Setiawan, D. Oktora, M. P. Hutubessy, R. Riewpaiboon, A. Postma, M. J.

The health-economic studies of HPV vaccination in Southeast Asian countries: a systematic review

  • South-East Asia
  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Economic aspects
  • Efficacy/effectiveness
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2017 ∙ Agarwal, Raksheeth Wahid, Mardiastuti H. Yausep, Oliver E. Angel, Sharon H. Lokeswara, Angga W.

The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review

  • Children
  • Adolescents
  • Dengue
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2017 ∙ Van Den Ende, Caroline Marano, Cinzia Van Ahee, Ayla Bunge, Eveline M. De Moerlooze, Laurence

The immunogenicity and safety of GSK's recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience

  • All age groups
  • Hepatitis B
  • Administration
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2017 ∙ Ende, C. van den Marano, C. Ahee, A. van Bunge, E. M. Moerlooze, L. de

The immunogenicity of GSK's recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience

  • Newborn
  • Children
  • Adolescents
  • Hepatitis B
  • Administration
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2017 ∙ Alicino, C. Paganino, C. Orsi, A. Astengo, M. Trucchi, C. Icardi, G. Ansaldi, F.

The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis

  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2017 ∙ Adamson, Blythe Dimitrov, Dobromir Devine, Beth Barnabas, Ruanne

The Potential Cost-Effectiveness of HIV Vaccines: A Systematic Review

  • All age groups
  • HIV / AIDS
  • Economic aspects
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2017 ∙ Loke, A. Y. Kwan, M. L. Wong, Y. T. Wong, A. K. Y.

The Uptake of Human Papillomavirus Vaccination and Its Associated Factors Among Adolescents: A Systematic Review

  • Adolescents
  • Adults
  • Parents/caregivers
  • Human papillomavirus (HPV)
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
Loading...